International comparison of glycaemic control in people with type 1 diabetes: an update and extension

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

International comparison of glycaemic control in people with type 1 diabetes : an update and extension. / Prigge, Regina; McKnight, John A.; Wild, Sarah H.; Haynes, Aveni; Jones, Timothy W.; Davis, Elizabeth A.; Rami-Merhar, Birgit; Fritsch, Maria; Prchla, Christine; Lavens, Astrid; Doggen, Kris; Chao, Suchsia; Aronson, Ronnie; Brown, Ruth; Ibfelt, Else H.; Svensson, Jannet; Young, Robert; Warner, Justin T.; Robinson, Holy; Laatikainen, Tiina; Rautiainen, Päivi; Delemer, Brigitte; Souchon, Pierre François; Diallo, Alpha M.; Holl, Reinhard W.; Schmid, Sebastian M.; Raile, Klemens; Tigas, Stelios; Bargiota, Alexandra; Zografou, Ioanna; Luk, Andrea O. Y.; Chan, Juliana C. N.; Dinneen, Sean F.; Buckley, Claire M.; Kgosidialwa, Oratile; Cherubini, Valentino; Gesuita, Rosaria; Strele, Ieva; Pildava, Santa; Veeze, Henk; Aanstoot, Henk-Jan; Mul, Dick; Jefferies, Craig; Cooper, John G.; Løvaas, Karianne Fjeld; Battelino, Tadej; Dovc, Klemen; Bratina, Nataša; Eeg-Olofsson, Katarina; Svensson, Ann-Marie; Gudbjornsdottir, Soffia; Globa, Evgenia; Zelinska, Nataliya.

I: Diabetic Medicine, Bind 39, Nr. 5, e14766, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Prigge, R, McKnight, JA, Wild, SH, Haynes, A, Jones, TW, Davis, EA, Rami-Merhar, B, Fritsch, M, Prchla, C, Lavens, A, Doggen, K, Chao, S, Aronson, R, Brown, R, Ibfelt, EH, Svensson, J, Young, R, Warner, JT, Robinson, H, Laatikainen, T, Rautiainen, P, Delemer, B, Souchon, PF, Diallo, AM, Holl, RW, Schmid, SM, Raile, K, Tigas, S, Bargiota, A, Zografou, I, Luk, AOY, Chan, JCN, Dinneen, SF, Buckley, CM, Kgosidialwa, O, Cherubini, V, Gesuita, R, Strele, I, Pildava, S, Veeze, H, Aanstoot, H-J, Mul, D, Jefferies, C, Cooper, JG, Løvaas, KF, Battelino, T, Dovc, K, Bratina, N, Eeg-Olofsson, K, Svensson, A-M, Gudbjornsdottir, S, Globa, E & Zelinska, N 2022, 'International comparison of glycaemic control in people with type 1 diabetes: an update and extension', Diabetic Medicine, bind 39, nr. 5, e14766. https://doi.org/10.1111/dme.14766

APA

Prigge, R., McKnight, J. A., Wild, S. H., Haynes, A., Jones, T. W., Davis, E. A., Rami-Merhar, B., Fritsch, M., Prchla, C., Lavens, A., Doggen, K., Chao, S., Aronson, R., Brown, R., Ibfelt, E. H., Svensson, J., Young, R., Warner, J. T., Robinson, H., ... Zelinska, N. (2022). International comparison of glycaemic control in people with type 1 diabetes: an update and extension. Diabetic Medicine, 39(5), [e14766]. https://doi.org/10.1111/dme.14766

Vancouver

Prigge R, McKnight JA, Wild SH, Haynes A, Jones TW, Davis EA o.a. International comparison of glycaemic control in people with type 1 diabetes: an update and extension. Diabetic Medicine. 2022;39(5). e14766. https://doi.org/10.1111/dme.14766

Author

Prigge, Regina ; McKnight, John A. ; Wild, Sarah H. ; Haynes, Aveni ; Jones, Timothy W. ; Davis, Elizabeth A. ; Rami-Merhar, Birgit ; Fritsch, Maria ; Prchla, Christine ; Lavens, Astrid ; Doggen, Kris ; Chao, Suchsia ; Aronson, Ronnie ; Brown, Ruth ; Ibfelt, Else H. ; Svensson, Jannet ; Young, Robert ; Warner, Justin T. ; Robinson, Holy ; Laatikainen, Tiina ; Rautiainen, Päivi ; Delemer, Brigitte ; Souchon, Pierre François ; Diallo, Alpha M. ; Holl, Reinhard W. ; Schmid, Sebastian M. ; Raile, Klemens ; Tigas, Stelios ; Bargiota, Alexandra ; Zografou, Ioanna ; Luk, Andrea O. Y. ; Chan, Juliana C. N. ; Dinneen, Sean F. ; Buckley, Claire M. ; Kgosidialwa, Oratile ; Cherubini, Valentino ; Gesuita, Rosaria ; Strele, Ieva ; Pildava, Santa ; Veeze, Henk ; Aanstoot, Henk-Jan ; Mul, Dick ; Jefferies, Craig ; Cooper, John G. ; Løvaas, Karianne Fjeld ; Battelino, Tadej ; Dovc, Klemen ; Bratina, Nataša ; Eeg-Olofsson, Katarina ; Svensson, Ann-Marie ; Gudbjornsdottir, Soffia ; Globa, Evgenia ; Zelinska, Nataliya. / International comparison of glycaemic control in people with type 1 diabetes : an update and extension. I: Diabetic Medicine. 2022 ; Bind 39, Nr. 5.

Bibtex

@article{4814acaae86f41cbb7f72c5b2b20bab5,
title = "International comparison of glycaemic control in people with type 1 diabetes: an update and extension",
abstract = "AIMS: To update and extend a previous cross-sectional international comparison of glycaemic control in people with type 1 diabetes.METHODS: Data were obtained for 520,392 children and adults with type 1 diabetes from 17 population and five clinic-based data sources in countries or regions between 2016 and 2020. Median HbA1c (IQR) and proportions of individuals with HbA1c < 58 mmol/mol (<7.5%), 58-74 mmol/mol (7.5-8.9%) and ≥75 mmol/mol (≥9.0%) were compared between populations for individuals aged <15, 15-24 and ≥25 years. Logistic regression was used to estimate the odds ratio (OR) of HbA1c < 58 mmol/mol (<7.5%) relative to ≥58 mmol/mol (≥7.5%), stratified and adjusted for sex, age and data source. Where possible, changes in the proportion of individuals in each HbA1c category compared to previous estimates were calculated.RESULTS: Median HbA1c varied from 55 to 79 mmol/mol (7.2 to 9.4%) across data sources and age groups so a pooled estimate was deemed inappropriate. OR (95% CI) for HbA1c < 58 mmol/mol (<7.5%) were 0.91 (0.90-0.92) for women compared to men, 1.68 (1.65-1.71) for people aged <15 years and 0.81 (0.79-0.82) aged15-24 years compared to those aged ≥25 years. Differences between populations persisted after adjusting for sex, age and data source. In general, compared to our previous analysis, the proportion of people with an HbA1c < 58 mmol/l (<7.5%) increased and proportions of people with HbA1c ≥ 75 mmol/mol (≥9.0%) decreased.CONCLUSIONS: Glycaemic control of type 1 diabetes continues to vary substantially between age groups and data sources. While some improvement over time has been observed, glycaemic control remains sub-optimal for most people with Type 1 diabetes.",
author = "Regina Prigge and McKnight, {John A.} and Wild, {Sarah H.} and Aveni Haynes and Jones, {Timothy W.} and Davis, {Elizabeth A.} and Birgit Rami-Merhar and Maria Fritsch and Christine Prchla and Astrid Lavens and Kris Doggen and Suchsia Chao and Ronnie Aronson and Ruth Brown and Ibfelt, {Else H.} and Jannet Svensson and Robert Young and Warner, {Justin T.} and Holy Robinson and Tiina Laatikainen and P{\"a}ivi Rautiainen and Brigitte Delemer and Souchon, {Pierre Fran{\c c}ois} and Diallo, {Alpha M.} and Holl, {Reinhard W.} and Schmid, {Sebastian M.} and Klemens Raile and Stelios Tigas and Alexandra Bargiota and Ioanna Zografou and Luk, {Andrea O. Y.} and Chan, {Juliana C. N.} and Dinneen, {Sean F.} and Buckley, {Claire M.} and Oratile Kgosidialwa and Valentino Cherubini and Rosaria Gesuita and Ieva Strele and Santa Pildava and Henk Veeze and Henk-Jan Aanstoot and Dick Mul and Craig Jefferies and Cooper, {John G.} and L{\o}vaas, {Karianne Fjeld} and Tadej Battelino and Klemen Dovc and Nata{\v s}a Bratina and Katarina Eeg-Olofsson and Ann-Marie Svensson and Soffia Gudbjornsdottir and Evgenia Globa and Nataliya Zelinska",
note = "{\textcopyright} 2021 Diabetes UK.",
year = "2022",
doi = "10.1111/dme.14766",
language = "English",
volume = "39",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - International comparison of glycaemic control in people with type 1 diabetes

T2 - an update and extension

AU - Prigge, Regina

AU - McKnight, John A.

AU - Wild, Sarah H.

AU - Haynes, Aveni

AU - Jones, Timothy W.

AU - Davis, Elizabeth A.

AU - Rami-Merhar, Birgit

AU - Fritsch, Maria

AU - Prchla, Christine

AU - Lavens, Astrid

AU - Doggen, Kris

AU - Chao, Suchsia

AU - Aronson, Ronnie

AU - Brown, Ruth

AU - Ibfelt, Else H.

AU - Svensson, Jannet

AU - Young, Robert

AU - Warner, Justin T.

AU - Robinson, Holy

AU - Laatikainen, Tiina

AU - Rautiainen, Päivi

AU - Delemer, Brigitte

AU - Souchon, Pierre François

AU - Diallo, Alpha M.

AU - Holl, Reinhard W.

AU - Schmid, Sebastian M.

AU - Raile, Klemens

AU - Tigas, Stelios

AU - Bargiota, Alexandra

AU - Zografou, Ioanna

AU - Luk, Andrea O. Y.

AU - Chan, Juliana C. N.

AU - Dinneen, Sean F.

AU - Buckley, Claire M.

AU - Kgosidialwa, Oratile

AU - Cherubini, Valentino

AU - Gesuita, Rosaria

AU - Strele, Ieva

AU - Pildava, Santa

AU - Veeze, Henk

AU - Aanstoot, Henk-Jan

AU - Mul, Dick

AU - Jefferies, Craig

AU - Cooper, John G.

AU - Løvaas, Karianne Fjeld

AU - Battelino, Tadej

AU - Dovc, Klemen

AU - Bratina, Nataša

AU - Eeg-Olofsson, Katarina

AU - Svensson, Ann-Marie

AU - Gudbjornsdottir, Soffia

AU - Globa, Evgenia

AU - Zelinska, Nataliya

N1 - © 2021 Diabetes UK.

PY - 2022

Y1 - 2022

N2 - AIMS: To update and extend a previous cross-sectional international comparison of glycaemic control in people with type 1 diabetes.METHODS: Data were obtained for 520,392 children and adults with type 1 diabetes from 17 population and five clinic-based data sources in countries or regions between 2016 and 2020. Median HbA1c (IQR) and proportions of individuals with HbA1c < 58 mmol/mol (<7.5%), 58-74 mmol/mol (7.5-8.9%) and ≥75 mmol/mol (≥9.0%) were compared between populations for individuals aged <15, 15-24 and ≥25 years. Logistic regression was used to estimate the odds ratio (OR) of HbA1c < 58 mmol/mol (<7.5%) relative to ≥58 mmol/mol (≥7.5%), stratified and adjusted for sex, age and data source. Where possible, changes in the proportion of individuals in each HbA1c category compared to previous estimates were calculated.RESULTS: Median HbA1c varied from 55 to 79 mmol/mol (7.2 to 9.4%) across data sources and age groups so a pooled estimate was deemed inappropriate. OR (95% CI) for HbA1c < 58 mmol/mol (<7.5%) were 0.91 (0.90-0.92) for women compared to men, 1.68 (1.65-1.71) for people aged <15 years and 0.81 (0.79-0.82) aged15-24 years compared to those aged ≥25 years. Differences between populations persisted after adjusting for sex, age and data source. In general, compared to our previous analysis, the proportion of people with an HbA1c < 58 mmol/l (<7.5%) increased and proportions of people with HbA1c ≥ 75 mmol/mol (≥9.0%) decreased.CONCLUSIONS: Glycaemic control of type 1 diabetes continues to vary substantially between age groups and data sources. While some improvement over time has been observed, glycaemic control remains sub-optimal for most people with Type 1 diabetes.

AB - AIMS: To update and extend a previous cross-sectional international comparison of glycaemic control in people with type 1 diabetes.METHODS: Data were obtained for 520,392 children and adults with type 1 diabetes from 17 population and five clinic-based data sources in countries or regions between 2016 and 2020. Median HbA1c (IQR) and proportions of individuals with HbA1c < 58 mmol/mol (<7.5%), 58-74 mmol/mol (7.5-8.9%) and ≥75 mmol/mol (≥9.0%) were compared between populations for individuals aged <15, 15-24 and ≥25 years. Logistic regression was used to estimate the odds ratio (OR) of HbA1c < 58 mmol/mol (<7.5%) relative to ≥58 mmol/mol (≥7.5%), stratified and adjusted for sex, age and data source. Where possible, changes in the proportion of individuals in each HbA1c category compared to previous estimates were calculated.RESULTS: Median HbA1c varied from 55 to 79 mmol/mol (7.2 to 9.4%) across data sources and age groups so a pooled estimate was deemed inappropriate. OR (95% CI) for HbA1c < 58 mmol/mol (<7.5%) were 0.91 (0.90-0.92) for women compared to men, 1.68 (1.65-1.71) for people aged <15 years and 0.81 (0.79-0.82) aged15-24 years compared to those aged ≥25 years. Differences between populations persisted after adjusting for sex, age and data source. In general, compared to our previous analysis, the proportion of people with an HbA1c < 58 mmol/l (<7.5%) increased and proportions of people with HbA1c ≥ 75 mmol/mol (≥9.0%) decreased.CONCLUSIONS: Glycaemic control of type 1 diabetes continues to vary substantially between age groups and data sources. While some improvement over time has been observed, glycaemic control remains sub-optimal for most people with Type 1 diabetes.

U2 - 10.1111/dme.14766

DO - 10.1111/dme.14766

M3 - Journal article

C2 - 34890078

VL - 39

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 5

M1 - e14766

ER -

ID: 301081691